Share on

Asia-Pacific Cell Harvesting Systems Market Research Report – Segmented By Application, End-user, Techniques & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: March, 2023
ID: 7895
Pages: 145
Formats: report pdf report excel report power bi report ppt

The size of the Asia Pacific Cell Harvesting Systems Market was around USD 0.36 billion in 2022. It is expected to grow at a CAGR of 6.50 % to reach USD 0.50 billion by 2027.

The cell harvesting systems market in the APAC region is mainly being propelled forward by factors such as rising demand for stem cell-based therapies and increased expenditure in clinical research.

The APAC market for cell harvesting systems is further predicted to be driven by an increase in bone marrow transplant operations due to the increasing frequency of blood malignancy and anemia. As the population ages, demand for stem cell-based therapy is predicted to rise, as is the incidence of chronic disorders like cardiovascular disease. Cell harvesting technologies improve scar repair by boosting pigmentation, which drives companies to engage in continual technical advances in cell separation techniques and downstream purification procedures. The need for cell harvesting systems is increasing faster due to the large concentration of bone marrow stem cell harvesting centers and registries and skilled clinicians to collect stem cells.

To generate regenerative medications, many businesses focus on cardiac tissue regeneration by the infusion of cell grafts made up of adult stem cells from patients. Various technical breakthroughs are projected to drive the cell harvesting systems market throughout the forecast period, resulting in new and better technologies with higher performance. Additionally, growing logistic facility investment, extending the bone marrow transplant registry for cardiac and neurological illnesses, and rising per capita healthcare spending are all elements to consider as market potential possibilities.

However, the APAC cell harvesting systems market is projected to be deterred by immune rejection and a lack of reimbursement rules. However, throughout the projection period, ethical concerns concerning embryonic stem cells and unlicensed stem cell treatment provided by healthcare providers in deregulated locations are projected to limit the market growth. The high cost of stem cell treatments and ethical concerns surrounding them may hinder the market's growth throughout the projected period.

The cell harvesting systems market faces numerous challenges, including the high cost of inconvenient therapy, viable cell density, and problems during cell harvesting, an insufficient number of HSCs (hematopoietic stem cells) cells for transplantation, and the identification of stem cells in adult tissues.

This research report on the APAC cell harvesting systems market has been segmented and sub-segmented into the following categories.

By Application:

  • Bone Marrow
  • Umbilical Cord
  • Adipose Tissue
  • Peripheral Blood

By End User:

  • Academic Institutes
  • Hospitals
  • Diagnostic Labs
  • Research Centers

By Technique:

  • Blastomere Extraction
  • Altered Nuclear Transfer

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Because of the increased frequency of chronic illnesses and rising demand for stem cell transplantation and stem cell-based therapy, the Asia Pacific region is expected to develop healthily throughout the projected period. In the Asia Pacific, harvesting systems are most popular in Japan and China. Urbanization, sedentary lifestyles, changing diets, growing obesity levels, and the broad availability of tobacco products contribute to cancer and heart disease being the leading causes of mortality in developing economies. The potential for stem cells to be used to treat a variety of chronic illnesses is driving the industry forward. As a result, market growth is likely boosted by the rising prevalence of chronic and infectious disorders.

During the anticipated period, Japan is likely to lead the Asia Pacific market for cell harvesting systems. Furthermore, due to its massive number of stem cell harvesting institutes from Bone Marrow, Japan will grow.

China, after Japan, holds the largest share of the APAC Cell Harvesting Systems market. Other key factors driving the market include an aging population and a growth in cardiovascular illnesses. Furthermore, the rising transplantation rate and the growing demand for stem cell banking contribute to the country's growing harvesting requirements. In addition, the cell harvesting market will benefit from the overall expansion of the biotechnology sector.


The leading players in the current market are Avita Medical; Tomtec; Terumo Corporation; Perkin Elmer, Inc; Argos Technologies, Inc; Bertin Technologies; Arthrex, Inc; Brand GmBh + CO KG; Thomas Scientific; and Tereflex, Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample